mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health
NCT ID: NCT05669040
Last Updated: 2022-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
278 participants
INTERVENTIONAL
2022-11-21
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient experience
Pharmacological education
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Training in the use of MyPlan Aplication
Review of the use of the aplication
Patient Experience
* How do you feel?
* Sad feelings and frustration.
* Achievements day by day, think positive.
* Importance of interpersonal relationships.
* Explain activities to relax the mind
Adherence to drug treatment
Pharmacological education
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Training in the use of MyPlan Aplication
Review of the use of the aplication
Positive mental health
Patient Experience
* How do you feel?
* Sad feelings and frustration.
* Achievements day by day, think positive.
* Importance of interpersonal relationships.
* Explain activities to relax the mind
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacological education
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Training in the use of MyPlan Aplication
Review of the use of the aplication
Patient Experience
* How do you feel?
* Sad feelings and frustration.
* Achievements day by day, think positive.
* Importance of interpersonal relationships.
* Explain activities to relax the mind
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* knowledge of the Spanish language
* 24-hour admission to the traumatology unit
* level of consciousness on the Glasgow scale of 15
* have access to a mobile device
* ability to participate in the pilot study
* be able to provide written informed consent or obtain consent from a legal representative.
Exclusion Criteria
* isolation in hospital admission
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
University of Barcelona
OTHER
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gemma Marcos
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carmen Moreno Arroyo
Role: STUDY_DIRECTOR
UB
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinic de Barcelona
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gemma Marcos
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Intervention EFE
Identifier Type: -
Identifier Source: org_study_id